Loading…
SGA / Dibenzodiazepine·Psychiatry - Antipsychotics
Treatment-resistant schizophrenia, reduction of suicidal behavior in schizophrenia
Max Dose
900 mg/day
Caution: Neutrophils
STRICT LIMITS
High risk: Myocarditis
CRITICAL
High risk: Constipation
FATAL RISK
Avoid / Cautions
History of clozapine-induced agranulocytosis or myocarditis. Uncontrolled epilepsy. Paralytic ileus. Pregnancy Category C. Avoid concurrent carbamazepine (bone marrow suppression / fatal agranulocytosis risk).
Overview
Antipsychotic for treatment-resistant schizophrenia. Treatment requires registration and blood monitoring through the clozapine monitoring service because of serious, potentially fatal adverse effects.
Clinical Focus
Serious adverse effects include agranulocytosis, myocarditis and paralytic ileus, which can be fatal. Start only with the monitoring the WA guideline requires (see the WA Health section below).
Bottom Line
Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, but requires mandatory regular blood monitoring due to risk of fatal agranulocytosis and causes severe metabolic syndrome.
Brand Names
Clozaril, Clopine
Oral Routes
Tablets (12.5, 25, 50, 100, 200 mg). Oral liquid.
Prescribing & PBS
Highly Restricted. Prescriber, Pharmacist, and Patient MUST be registered with the Clozapine Patient Monitoring System (CPMS).
Primary
Treatment-resistant schizophrenia, reduction of suicidal behavior in schizophrenia.
Clinical Place
Reserved for treatment-resistant schizophrenia. Has evidence for reducing suicidal behaviour in schizophrenia.
No calculator, monitoring schedule or factsheet is linked to this medicine page yet.